MMPI-2 profiles of persons with multiple chemical sensitivity

Laurence M. Binder, Daniel Storzbach, Martin Salinsky

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We compared the MMPI-2 profiles of adults with multiple chemical sensitivity (MCS), epileptic seizures (ES), and nonepileptic seizures (NES). Both NES and MCS are medically unexplained conditions. In previous studies profiles associated with NES were elevated on scales Hs and Hy, compared with profiles associated with ES. We predicted that profiles associated with MCS would be elevated on Hs and Hy compared with the ES group. Patients with ES and NES were diagnosed after intensive EEG monitoring using published criteria. MCS was diagnosed if there was a complaint of illness in response to multiple common odors at levels that are not noxious to most people. All the MCS cases had legal claims for injury related to chemical exposures. The results showed that on MMPI-2 scales Hs, D, and Hy the MCS group had means significantly higher than both the ES and NES groups. Fake Bad Scale scores were elevated in 11 MCS cases, and regression-based estimates of Fake Bad Scale scores showed elevation in the MCS group compared with both seizure groups. We conclude that MMPI-2 data, obtained from people seeking financial compensation, indicate that there is a strong psychological component to MCS symptoms.

Original languageEnglish (US)
Pages (from-to)848-857
Number of pages10
JournalClinical Neuropsychologist
Volume20
Issue number4
DOIs
StatePublished - Dec 1 2006

Fingerprint

Multiple Chemical Sensitivity
MMPI
Seizures
Epilepsy
Person
Electroencephalography
Psychology

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

MMPI-2 profiles of persons with multiple chemical sensitivity. / Binder, Laurence M.; Storzbach, Daniel; Salinsky, Martin.

In: Clinical Neuropsychologist, Vol. 20, No. 4, 01.12.2006, p. 848-857.

Research output: Contribution to journalArticle

Binder, Laurence M. ; Storzbach, Daniel ; Salinsky, Martin. / MMPI-2 profiles of persons with multiple chemical sensitivity. In: Clinical Neuropsychologist. 2006 ; Vol. 20, No. 4. pp. 848-857.
@article{2b336a7fbe95466ea44b24401e555da3,
title = "MMPI-2 profiles of persons with multiple chemical sensitivity",
abstract = "We compared the MMPI-2 profiles of adults with multiple chemical sensitivity (MCS), epileptic seizures (ES), and nonepileptic seizures (NES). Both NES and MCS are medically unexplained conditions. In previous studies profiles associated with NES were elevated on scales Hs and Hy, compared with profiles associated with ES. We predicted that profiles associated with MCS would be elevated on Hs and Hy compared with the ES group. Patients with ES and NES were diagnosed after intensive EEG monitoring using published criteria. MCS was diagnosed if there was a complaint of illness in response to multiple common odors at levels that are not noxious to most people. All the MCS cases had legal claims for injury related to chemical exposures. The results showed that on MMPI-2 scales Hs, D, and Hy the MCS group had means significantly higher than both the ES and NES groups. Fake Bad Scale scores were elevated in 11 MCS cases, and regression-based estimates of Fake Bad Scale scores showed elevation in the MCS group compared with both seizure groups. We conclude that MMPI-2 data, obtained from people seeking financial compensation, indicate that there is a strong psychological component to MCS symptoms.",
author = "Binder, {Laurence M.} and Daniel Storzbach and Martin Salinsky",
year = "2006",
month = "12",
day = "1",
doi = "10.1080/13854040500246927",
language = "English (US)",
volume = "20",
pages = "848--857",
journal = "Clinical Neuropsychologist",
issn = "1385-4046",
publisher = "Swets & Zeitlinger",
number = "4",

}

TY - JOUR

T1 - MMPI-2 profiles of persons with multiple chemical sensitivity

AU - Binder, Laurence M.

AU - Storzbach, Daniel

AU - Salinsky, Martin

PY - 2006/12/1

Y1 - 2006/12/1

N2 - We compared the MMPI-2 profiles of adults with multiple chemical sensitivity (MCS), epileptic seizures (ES), and nonepileptic seizures (NES). Both NES and MCS are medically unexplained conditions. In previous studies profiles associated with NES were elevated on scales Hs and Hy, compared with profiles associated with ES. We predicted that profiles associated with MCS would be elevated on Hs and Hy compared with the ES group. Patients with ES and NES were diagnosed after intensive EEG monitoring using published criteria. MCS was diagnosed if there was a complaint of illness in response to multiple common odors at levels that are not noxious to most people. All the MCS cases had legal claims for injury related to chemical exposures. The results showed that on MMPI-2 scales Hs, D, and Hy the MCS group had means significantly higher than both the ES and NES groups. Fake Bad Scale scores were elevated in 11 MCS cases, and regression-based estimates of Fake Bad Scale scores showed elevation in the MCS group compared with both seizure groups. We conclude that MMPI-2 data, obtained from people seeking financial compensation, indicate that there is a strong psychological component to MCS symptoms.

AB - We compared the MMPI-2 profiles of adults with multiple chemical sensitivity (MCS), epileptic seizures (ES), and nonepileptic seizures (NES). Both NES and MCS are medically unexplained conditions. In previous studies profiles associated with NES were elevated on scales Hs and Hy, compared with profiles associated with ES. We predicted that profiles associated with MCS would be elevated on Hs and Hy compared with the ES group. Patients with ES and NES were diagnosed after intensive EEG monitoring using published criteria. MCS was diagnosed if there was a complaint of illness in response to multiple common odors at levels that are not noxious to most people. All the MCS cases had legal claims for injury related to chemical exposures. The results showed that on MMPI-2 scales Hs, D, and Hy the MCS group had means significantly higher than both the ES and NES groups. Fake Bad Scale scores were elevated in 11 MCS cases, and regression-based estimates of Fake Bad Scale scores showed elevation in the MCS group compared with both seizure groups. We conclude that MMPI-2 data, obtained from people seeking financial compensation, indicate that there is a strong psychological component to MCS symptoms.

UR - http://www.scopus.com/inward/record.url?scp=33748799407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748799407&partnerID=8YFLogxK

U2 - 10.1080/13854040500246927

DO - 10.1080/13854040500246927

M3 - Article

VL - 20

SP - 848

EP - 857

JO - Clinical Neuropsychologist

JF - Clinical Neuropsychologist

SN - 1385-4046

IS - 4

ER -